It is contraindicated in women of childbearing potential due to the risk of feminisation of a male foetus
Warning Signs to Watch For If you do choose to drink while on GLP-1 therapy, Agrawal advises stopping and seeking medical advice if you experience: Dizziness, confusion, sweating, shakiness, or slurred speech Severe or persistent nausea and vomiting Abdominal pain that could suggest pancreatitis Feeling unusually impaired despite drinking a small amount Worsened hangovers compared to your normal experience Trouble thinking clearly or coordinating movements Any of these symptoms are a reason to stop drinking and seek medical guidance, Agrawal says
To kick off 2026, Roche won FDA approval for subcutaneous Lunsumio Velo (mosunetuzumab) in follicular lymphoma
Coconut water replaces electrolytes that GLP-1 medications can deplete, making this an excellent choice if you are dealing with lightheadedness on semaglutide
Accurate disclosures at the underwriting stage may need to be validated at the claims stage, and claims assessors will require a deep understanding of the use of AOMs to ensure accurate interpretation of disclosures made as part of the insurance application
Patients with personal or family history of medullary thyroid cancer, multiple endocrine neoplasia type 2, or severe pancreatitis should avoid semaglutide